The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, J.-E.
Right arrow Articles by Kupper, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, J.-E.
Right arrow Articles by Kupper, T. S.
Right arrowPubmed/NCBI databases
*Gene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*12-O-TETRADECANOYLPHORBOL-13-ACETATE
*7,12-DIMETHYLBENZ(A)ANTHRACENE
*Genetics Home Reference
Medline Plus Health Information
*Skin Cancer
The Journal of Immunology, 2003, 170: 5697-5703.
Copyright © 2003 by The American Association of Immunologists

IL-1{alpha}, Innate Immunity, and Skin Carcinogenesis: The Effect of Constitutive Expression of IL-1{alpha} in Epidermis on Chemical Carcinogenesis1

Jo-Ellen Murphy, Romeo E. Morales2, Jordan Scott3 and Thomas S. Kupper4

Department of Dermatology, Harvard Skin Disease Research Center, Brigham and Women’s Hospital, Boston, MA 02115

Tumor promoters such as the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) are proinflammatory agents, and their mechanism of action in epithelial carcinogenesis has been linked to the release of IL-1{alpha} and the induction of chronic inflammation in skin. To test the role of IL-1{alpha} and inflammation in models of cutaneous carcinogenesis, we used our previously described FVB/N transgenic mice overexpressing 17-kDa IL-1{alpha} in the epidermis under the keratin 14 (K14) promoter. Strikingly, the K14/IL-1{alpha} mice were completely resistant to papilloma and carcinoma formation induced by a two-stage DMBA/TPA protocol, while littermate controls developed both tumor types. K14/IL-1{alpha} mice crossed with the highly sensitive TG.AC mice, constitutively expressing mutant Ha-Ras, also failed to develop papillomas or carcinomas. When the K14/IL-1{alpha} transgene was bred onto a recombinase-activating gene-2-deficient background, the resistance persisted, indicating that innate, but not acquired, mechanisms may be involved in the resistance to the initiation/promotion model. As an alternative approach, a complete carcinogenesis protocol using repetitive application of DMBA alone was applied. Surprisingly, although the IL-1{alpha} mice still did not develop papillomas, they did develop carcinomas de novo at an accelerated rate compared with controls. We conclude that constitutive IL-1{alpha} expression rendered FVB mice completely resistant to carcinomas that required evolution from prior papillomas, but facilitated carcinomas that did not evolve from papillomas, as in the complete carcinogenesis protocol. Thus, the role of IL-1{alpha} and, by extension that of other proinflammatory factors, in epithelial carcinogenesis are more complex than previously appreciated. These mice may provide a mechanism to investigate the validity of these models of human skin tumorigenesis.




This article has been cited by other articles:


Home page
 CarcinogenesisHome page
A. B. Glick, R. Perez-Lorenzo, and J. Mohammed
Context-dependent regulation of cutaneous immunological responses by TGF{beta}1 and its role in skin carcinogenesis
Carcinogenesis, January 1, 2008; 29(1): 9 - 14.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
D. Lynch, J. Svoboda, S. Putta, H. E. J. Hofland, W. H. Chern, and L. A. Hansen
Mouse Skin Models for Carcinogenic Hazard Identification: Utilities and Challenges
Toxicol Pathol, December 1, 2007; 35(7): 853 - 864.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. S. Miller, E. M. Pietras, L. H. Uricchio, K. Hirano, S. Rao, H. Lin, R. M. O'Connell, Y. Iwakura, A. L. Cheung, G. Cheng, et al.
Inflammasome-Mediated Production of IL-1beta Is Required for Neutrophil Recruitment against Staphylococcus aureus In Vivo
J. Immunol., November 15, 2007; 179(10): 6933 - 6942.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
O. V. Kovalenko, X. H. Yang, and M. E. Hemler
A Novel Cysteine Cross-linking Method Reveals a Direct Association between Claudin-1 and Tetraspanin CD9
Mol. Cell. Proteomics, November 1, 2007; 6(11): 1855 - 1867.
[Abstract] [Full Text] [PDF]

Home page
 CSH ProtocolsHome page
R. B. Filler, S. J. Roberts, and M. Girardi
Cutaneous Two-Stage Chemical Carcinogenesis
CSH Protocols, September 1, 2007; 2007(18): pdb.prot4837 - pdb.prot4837.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
V. Ablamunits, Y. Cohen, I. B. Brazee, H. P. Gaetz, C. Vinson, and S. Klebanov
Susceptibility to Induced and Spontaneous Carcinogenesis Is Increased in Fatless A-ZIP/F-1 but not in Obese ob/ob Mice.
Cancer Res., September 1, 2006; 66(17): 8897 - 8902.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. M. Sung, G. He, and S. M. Fischer
Lack of Expression of the EP2 but not EP3 Receptor for Prostaglandin E2 Results in Suppression of Skin Tumor Development
Cancer Res., October 15, 2005; 65(20): 9304 - 9311.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
J. Fuhrman, L. Shafer, S. Repertinger, T. Chan, and L. A. Hansen
Mechanisms of SEPA 0009-Induced Tumorigenesis in v-rasHa Transgenic Tg.AC Mice
Toxicol Pathol, October 1, 2005; 33(6): 623 - 630.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.